Back to Search
Start Over
Functional frontal lobectomy in the surgical treatment of pharmacoresistant frontal lobe epilepsy: how I do it.
- Source :
-
Acta neurochirurgica [Acta Neurochir (Wien)] 2024 Jul 18; Vol. 166 (1), pp. 299. Date of Electronic Publication: 2024 Jul 18. - Publication Year :
- 2024
-
Abstract
- Background: Frontal lobe epilepsy is pharmacoresistant in 30% of cases, constituting 10-20% of epilepsy surgeries. For cases of no lesional epilepsy (negative MRI), frontal lobectomy is a crucial treatment, historically involving Frontal Anatomical Lobectomy (AFL) with a 33.3% complication risk and 55.7% seizure control.<br />Methods: We describe Frontal Functional Lobectomy (FFL), in which the boundaries are defined on the patient's functional cortico-subcortical areas, recognized with advanced intraoperative technologies such as tractography and navigated transcranial magnetic stimulation (nTMS).<br />Conclusions: The FFL allows for a broader resection with a lower rate of postoperative complications than the AFL.<br /> (© 2024. The Author(s).)
- Subjects :
- Humans
Neuronavigation methods
Neurosurgical Procedures methods
Transcranial Magnetic Stimulation methods
Treatment Outcome
Drug Resistant Epilepsy surgery
Drug Resistant Epilepsy diagnostic imaging
Epilepsy, Frontal Lobe surgery
Epilepsy, Frontal Lobe diagnostic imaging
Frontal Lobe surgery
Frontal Lobe diagnostic imaging
Subjects
Details
- Language :
- English
- ISSN :
- 0942-0940
- Volume :
- 166
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Acta neurochirurgica
- Publication Type :
- Academic Journal
- Accession number :
- 39020068
- Full Text :
- https://doi.org/10.1007/s00701-024-06176-x